Orange Book product · Brand (NDA)
RIOMET ER
METFORMIN HYDROCHLORIDE
At a glance
Aug 29, 2019
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 29, 2019
6 yr 11 mo ago
Today
Patent 9962336 expires
Listed drug product patent expiration.
May 01, 2035
in 9 yr
Pharmaceutical detail
Active ingredient
METFORMIN HYDROCHLORIDE
Strength
500MG/5ML
Dosage form
FOR SUSPENSION, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 212595
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2005GLUMETZABrand (NDA)
NDA 021748 · SANTARUS INC
- 2004FORTAMETBrand (NDA)
NDA 021574 · ANDRX LABS LLC
- 2003RIOMETBrand (NDA)
NDA 021591 · RANBAXY
- 2000GLUCOPHAGE XRBrand (NDA)
NDA 021202 · EMD SERONO INC
- 2025METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 219151 · BIONPHARMA
- 2025METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215008 · ANNORA PHARMA
- 2024METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 209694 · AUROBINDO PHARMA
- 2024METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 218673 · HARMAN FINOCHEM
- 2024METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 211163 · MACLEODS PHARMS LTD
- 2023METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 217631 · LAURUS
- 2023METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 212448 · MICRO LABS
- 2022METFORMIN HYDROCHLORIDEGeneric (ANDA)
ANDA 212677 · VISTAPHARM LLC
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9962336 | May 01, 2035 | in 9 yr | Product |

